INTRODUCTION
G protein-mediated signaling is intrinsically kinetic. Signal amplitude is determined by the balance of the rates of GDP/GTP exchange (activation) and of the rates of GTP hydrolysis (deactivation); this balance determines the amount of G protein in the activated GTP-bound state. The activation limb of the GTPase cycle is accelerated by G protein-coupled receptors (GPCRs); the deactivation limb is accelerated by GTPase-activating proteins (GAPs). GAPs for heterotrimeric G proteins include two G protein-regulated effectors, the G q -stimulated phospholipase C-β (PLC-β) and the G 13 -stimulated p115RhoGEF. The recently identified regulators of G protein signaling (RGS) proteins, which are found throughout the higher eukaryotes, are also G protein GAPs. This review focuses on their mechanisms of action and roles in signal modulation.
GTP hydrolysis was initially thought to be an unregulated function of Gα subunits that provides an intrinsic control over the activation lifetime of a G protein.
This idea was consistent with the first report of the rate of hydrolysis of GTP bound to G s (1) , which corresponded well to the rate of deactivation of adenylyl cyclase in a plasma membrane (2) . Both events displayed half-lives of ∼15 s. However, other G proteins that mediate responses with rapid recovery rates (t 1/2 < 1 s) displayed similarly slow hydrolysis rates in vitro (3) . Vision presented a particularly obvious inconsistency between rates of hydrolysis and deactivation (3, 4) ; the half-time for hydrolysis of GTP bound to isolated G t is ∼15 s, but light responses terminate much more quickly (∼100 ms). Several studies indicated that the rate of Gα t -catalyzed GTP hydrolysis in intact photoreceptor cells is as fast as physiologic deactivation, which suggests that a GTPase-accelerating factor was lost upon purification of G t (5) (6) (7) (8) .
The discrepancy between fast physiologic deactivation rates and slow in vitro GTP hydrolysis rates prompted the first searches for proteins that would accelerate hydrolysis of Gα-bound GTP. Effort was further stimulated by the discovery of a GAP for the monomeric GTP-binding protein p21ras (9, 10) . Two G protein GAP activities were finally identified in 1992. Berstein et al (11) found that PLC-β, the principal effector protein regulated by G q , also has selective G q GAP activity in that it could accelerate GTP hydrolysis by G q ≥ 50-fold. Arshavsky & Bownds (12) found that the addition of the regulatory γ subunit of cyclic GMP phosphodiesterase (PDE) to washed photoreceptor membranes accelerated the hydrolysis of GTP by G t (transducin) 4-5-fold. G t is the proximal activator of the PDE in photoreceptor cells, and PDE thus appeared to be another effector with intrinsic GAP activity. PDEγ was subsequently shown not to be a G t GAP itself, but it does potentiate the GAP activity of RGS9 (13) . More recently, a RhoGEF was also shown to be both an effector for G 13 and a G 13/12 -selective GAP (14, 15) .
RGS proteins were independently identified by three groups. Siderovski and coworkers (16) first identified this gene family, but they were initially misled about its function because of an apparent basic helix-loop-helix motif in the prototype, GOS8 (renamed RGS2). However, they did notice similarity to Sst2p, a feedback inhibitor of a Gα subunit that mediates the mating response in yeast (see 17 for review). De Vries et al (18) then showed that GAIP (Gα-interacting protein), a related protein, binds to Gα subunits. The reality of RGS proteins as G protein regulators gained further support when Koelle & Horvitz (19) reported that Egl-10 is an inhibitor of G o in Caenorhabditis elegans and is related to Sst2p, GOS8, GAIP, and several mammalian expressed sequence tags (ESTs). Shortly thereafter, Berman et al (20) and others (21) (22) (23) showed that RGS proteins display GAP activity toward members of the Gα i and Gα q families.
At this time, >20 mammalian RGS proteins have been identified, as have several more distantly related protein families ( Figure 1 ; see below). Most RGS proteins and several of their relatives display G protein GAP activity. The physiological functions of G protein GAP activity is known in only a few cases: feedback inhibition of the mating pheromone response in yeast, acceleration of termination of the photoresponse in the eye, and inhibitory signaling in neurons of C. elegans. The discovery of new and different functions can be expected. GAPs have the potential to inhibit signaling by depleting the GTP-activated form of Gα, to change signaling kinetics, or to alter signal specificity. RGS proteins also interact with a variety of other proteins and lipids, and may thus exert both positive and negative regulatory functions distinct from, or in addition to, their GAP activity. This review aims to convey what is known about the action of RGS proteins and other G protein GAPs, as well as to point out possible new functions of this recently recognized class of proteins. Because G protein signaling is found throughout the eukaryotes, interest in RGS proteins extends from basic biochemistry through whole-animal biology. Other reviews with multiple viewpoints are also available (24) (25) (26) (27) (28) (29) (30) (31) (32) . Figure 2 ). The scale shows approximate amino acid identity calculated as 100% minus the sum of the horizontal distance to and from the common branch point (e.g. axin and conductin are 64% identical). All sequences are human except for RGS8 (rat), RGSZ2 (mouse), and RET-RGS1 (bovine). Ortholog/paralog relationships remain uncertain for RET-RGS1 and RGSZ1; the only cloned RET-RGS1 cDNA is bovine and the only RGSZ1 cDNAs are murine and human. Accession numbers: GAIP (AAC62919); RGSZ1 (AAC62013); RGSZ2 (AF191555); RET-RGS1 (AAC48721); RGS1 (Q08116); RGS2 (P41220); RGS3 (P49796); RGS4 (P49798); RGS5 (O15539); RGS6 (P49758); RGS7 (P49802); RGS8 (P49804); RGS9 (AAC64040); RGS10 (O43665); RGS11 (AAC69175); RGS12 (AAC39835); RGS13 (O14921); RGS14 (O43566); RGS16 (AAC39642); axin (AAC51624); conductin (AAD20976). Right: Most proteins within each subfamily are also homologous in regions flanking the RGS domain; homologies include definable functional domains shown as labeled blocks on the diagrams of each protein's structure. Functions of these domains, where known, are discussed in the text. Abbreviations: APC, adenomatous polyposis coli; GGL, Gγ -like; DEP, PDZ, and PTB, protein interaction domains; PP2A, protein phosphatase 2A; GSK.
STRUCTURE AND PHYLOGENETIC RELATIONSHIPS OF RGS PROTEINS
The RGS proteins are related by a conserved RGS domain that is ∼130 amino acid residues in length ( Figure 1 ). The RGS domain alone is capable of binding Gα subunits and accelerating GTP hydrolysis (33, 34) , although other domains may contribute to affinity and/or selectivity for G protein targets (33, 35) . RGS domains have been found in fungi, Dictyostelium discoideum, and animals. They are yet to be identified in higher plants, although plants express both heterotrimeric G proteins and GPCRs.
The mammalian RGS proteins, of which >20 are now known, can be grouped into five subfamilies based on sequence similarity within the RGS domain (Figure 2 ; see 29 for an alternative grouping). Regions outside the RGS domain also show similarity within each subfamily. RGS proteins in the RZ, R4, R7, and R12 subfamilies all display GAP activity. We group the RA subfamily (axin and conductin) with the RGS proteins because of sequence similarity, although these proteins have not been shown to have GAP activity or to bind Gα subunits. We refer to proteins with domains more distantly related to the RGS domain as RGSlike (or RGL) proteins. These include the GPCR kinases (GRKs), some of which display GAP activity (36, 37) ; D-AKAP2, neither of whose RGL domains have yet been shown to bind to a Gα subunit 38 (RK Sunahara & SS Taylor, manuscript in preparation); and the p115RhoGEFs, which are both stimulated by Gα 13 and are G 13/12 GAPs (14, 15) . The C-terminal GAP domain of PLC-β (40) is the most distantly related to the RGS domain, if at all, but we include PLC-β in the RGL proteins because of its GAP activity. Sequence similarity among the RGL domains is listed in the legend to Figure 2 ; other sequence alignments have been proposed elsewhere (15, 36, 38) . It seems most likely that the RGL proteins evolved from an ancestor common to the RGS proteins, although convergent evolution from distinct gene lineages remains plausible for the RhoGEFs and likely for the PLC-βs.
The RGS Domain
The structure of the RGS domain was defined by X-ray crystallographic analysis of a complex of RGS4 and Gα i1 by Tesmer et al (41) . Although the crystals contained both intact proteins, only the 128-amino-acid RGS domain was resolved within RGS4; the N-and C-terminal regions (50 and 27 residues) were disordered. The correspondence of the genetically conserved sequence to the ordered structure supports the identity of the RGS domain as a discrete unit of folding and function. The RGS4 structure was complemented by an NMR structure of a fragment of GAIP that included only the RGS domain (42) . The overall structures of the two RGS domains are strikingly similar, which suggests that the RGS domain does not undergo major changes when it binds a Gα subunit. The only significant difference between the structures lies in an interhelix loop that is a point of contact with Gα. This difference probably reflects changes that occur upon Gα binding, rather than a difference between RGS4 and GAIP, because the sequence of this region is conserved among RGS proteins (Figures 2 and 3) .
The RGS domain ( Figure 3 ) is a globular and mostly helical structure based on a four-helix bundle (helices 4-7) and a second subdomain composed of the Nand C-terminal helices 1-3 and 8-9 ( Figure 3 ). Further truncation of this minimal domain has not produced active protein (33, 34) , which suggests the importance of both subdomains for overall stability and activity. Some of the most conserved residues among the RGS and RGL proteins are those that face into the helical bundles and are presumably important for structural stability. Other conserved residues contribute to Gα binding (41, 42a) . The RGS domain makes principal contact with Gα over a discontinuous interface that includes three nearby interhelix loops: 3/4, 5/6, and 7/8. They make contact with all three of the switch regions in the GTP-binding ras-like domain of Gα. The switch regions demonstrate the greatest changes in structure upon activation and deactivation. The RGS domain does not make direct contact with bound GTP, which supports the idea that it does not directly take part in hydrolysis. This mechanism contrasts with that of GAPs for the monomeric GTP-binding proteins (ras, etc.), which insert a catalytically important arginine residue into the GTP-binding site (43) . The cognate arginine in Gα subunits is provided by the helical domain of the Gα subunit (44) . The structure of the RGS-Gα interface, particularly the pattern of stabilization of the Switch II region on Gα, is discussed below in terms of the mechanism of GAP activity.
Analysis of the five RGS subfamilies points to other regions of functional importance. Many positions within the RGS domain contain residues found primarily in one subfamily (Figure 2 and 3 ; see also 42a). Among the RGS GAPs, these residues are most frequent on the front face of helices 2 and 3, on the back face of helices 6 and 7, and on loops 4/5 and 5/6. They include residues necessary for overall structure and for the Gα contact sites, but they also appear to perform other functions. Helix 7 is a particularly interesting example because it lies immediately adjacent to the most conserved portion of the RGS domain (helices 3, 4, and 8). It contains six residues conserved in nearly all RGS GAPs, interspersed with several subfamily-specific residues. This pattern suggests that helix 7 provides important Amino acid sequence alignment of the RGS domains from a representative member of each mammalian RGS subfamily (for complete alignment, see www.Annual Reviews.org). The features noted in the mammalian RGS domain include the position of the α-helices in RGS4 and GAIP (rods) (41, 42) , Gα contact residues (diamonds) (41), highly conserved amino acid identities (black), amino acid similarities (gray), and subfamily-specific residues in R4 (blue), RZ (orange), R7 (green), R12 (red), and RA (purple). G i and/or G q GAP activity has been observed for all RGS proteins except the RA subfamily. Similarity/identity of amino acid residues in representative RGS and RGL proteins to the overall consensus sequence in the 127-amino-acid core domain are as follows: RGSZ1, 48/39%; RGS4, 50/40%; RGS7, 43/37%; RGS12, 43/37%; axin, 37/28%; D-AKAPb, 24/18%; GRK2, 24/18%; GRK1, 23/19%; p115RhoGEF, 14/11%.
Figure 3
Relative conservation of amino acid sequence in the RGS family mapped onto the structure of the RGS domain of RGS4. Amino acid sequence alignments of all members of the RZ, R4, R7, and R12 subfamilies were generated (see www.AnnualReviews.org, Electronic Materials), and percent identity at each position was calculated. Relative conservation at each position was mapped onto the structure of RGS4 (41) . Top: RGS domain with the Gα contact surface below. contacts for binding to subfamily-specific regulatory proteins and that it may be an excellent target for mutational studies to test the function(s) of such proteins.
Several RGS and RGL proteins contain sizable inserts in the 4/5 and 6/7 loops of the RGS domain, the side opposite that of the Gα binding site. The functions of these inserts are mostly unknown, but they may mediate interactions with other regulatory molecules (e.g. reference 45). 1 
Conserved Domains in RGS-Flanking Regions
Even the shortest RGS and RGL proteins have recognizable functional domains and motifs within their flanking sequences. These modules, most of which mediate protein-protein interactions, are unique to individual subfamilies (Figure 1 ). Such grouping suggests that these flanking domains contribute to subfamily-specific activities, subcellular localization, or regulation. Specific functions of these domains, where known, are referred to elsewhere in this review. Flanking sequences in the RGL proteins also have clearly defined and independent regulatory functions: protein kinase activity in GRKs, GEF activity in the p115s, and phospholipase activity in the PLC-βs.
MECHANISM AND CONSEQUENCES OF G PROTEIN GAP ACTIVITY
GAPs bind the activated form of Gα and increase the rate at which bound GTP is hydrolyzed (Scheme I). Isolated Gα subunits hydrolyze bound GTP slowly, with rate constants (k hyd ) between 0.1 min −1 (G z ) and 2-4 min
• C (46). These rates correspond to half-lives for the GTP-activated state of 10 s to 7 min and are much too slow to account for the rates of deactivation in most G protein signaling pathways. GAPs accelerate GTP hydrolysis by as much as 2000-fold, such that GAP-stimulated hydrolysis rates (k gap ) measured in vitro correspond to or exceed cellular deactivation rates. For example, PLC-β1 accelerates hydrolysis of its upstream activator Gα q -GTP > 1000-fold, from k hyd = 0.012 s , >2000-fold above k hyd (47) . RGS4 also accelerates hydrolysis of Gα o -GTP > 1000-fold, and RGSZ1, RGS-GAIP, and RET-RGS1 stimulate hydrolysis of Gα z -GTP >400-fold (48, 49) . Although some GAPs may be less efficient, many reports of smaller rate enhancements (<100-fold) probably reflect either suboptimal assay conditions or an inappropriate Gα-GTP substrate (47, 50) .
GAP activity is usually assayed in vitro by measuring the rate of hydrolysis of [γ -
32 P]GTP prebound to a purified Gα, referred to as a "single turnover" assay because each Gα hydrolyzes only one molecule of labeled GTP. GAP activity is then quantitated as if the GAP were an enzyme that converts a Gα-GTP substrate to the products Gα-GDP and Pi (Scheme I). This convention allows definition of (48, 49) . Although subcellular localization of RGS proteins and their assembly into multiprotein signaling complexes may significantly influence RGS-Gα selectivities in vivo, values of K m should be a good estimate of the relative stability of RGS-Gα complexes in cells and may suggest which GAPs act on which Gα subunits. Note that an RGS molecule can sequentially bind and drive GTP hydrolysis on multiple molecules of Gα-GTP during a "single-turnover assay." RGS proteins can thus act catalytically, consistent with their formally enzyme-like behavior. Such catalytic behavior may be infrequent in cells, however, where RGS proteins may be relatively stably associated with G proteins and receptors during signal transduction.
GAP activity can also be detected more sensitively, and probably in a more physiological context, by monitoring the acceleration of agonist-stimulated steady-state GTPase activity in a system composed of trimeric G protein, receptor, and GAP reconstituted in phospholipid vesicles (48, 50, 55) . In such assays, the receptor promotes GDP/GTP exchange such that hydrolysis becomes largely rate-limiting, and GAP activity is monitored as an increase in steady-state GTPase rate. The sensitivity of this assay probably reflects both orientational effects of the phospholipid bilayer on the interaction of receptor, G protein, and GAP and important mechanistic interactions among the proteins (47, 56) . Absolute quantitation is more difficult in this format because rate acceleration depends both on the GAP and on the efficiency of receptor-G protein coupling. Quantitation of GAP activity in vitro and the relative utilities of different GAP assays have been discussed in detail elsewhere (50) .
Mechanism of G-Protein GAP Activity
Unlike GAPs for most of the monomeric GTP-binding proteins, GAPs for Gα subunits do not directly take part in the chemistry of GTP hydrolysis but rather alter the conformation of the Gα-GTP complex such that it becomes a better hydrolase (41, 57) . The mechanism of GAP action is therefore based on the multistep reaction scheme by which Gα subunits bind and hydrolyze GTP (Scheme II). After Gα binds GTP (reaction 1), the initial low-affinity Gα-GTP complex converts to the active form Gα * -GTP (reaction 2), which can stimulate effector proteins and which has reduced affinity for Gβγ (46) . Formation of Gα * -GTP requires Mg 2+ and can be monitored by enhanced fluorescence of a conserved tryptophan residue near the GTP binding site (58, 59) . Hydrolysis of bound GTP proceeds through a bipyramidal transition state intermediate, Gα
‡ -GTP (reaction 3). It was fortuitously possible to determine the probable conformation of this intermediate because AlF − 4 binds to Gα-GDP at the site usually occupied by the gamma phosphoryl group of GTP and approximates the bipyramidal hydrolytic intermediate (44, (60) (61) (62) . Gα-GDP-AlF 4 , which is activated insofar as it regulates effectors and binds Gβγ weakly (46) , has a conformation distinct from those of Gα are essentially concomitant; no Gα-GDP-Pi species has been observed during steady-state hydrolysis (although bound orthophosphate has been observed in some crystals (67) . The detailed chemical mechanism of these reactions has been reviewed by Sprang (44) .
By definition, GAPs act by decreasing the activation energy for hydrolysis G ‡ , either by energetically stabilizing the Gα ‡ -GTP transition state complex or by relatively destabilizing the preceding lower-energy state (presumably Gα * -GTP). The importance of stabilizing the Gα ‡ -GTP state was supported by the finding of Berman et al (68) that RGS4 binds more tightly to the transition state analog Gα i1 -GDP/AlF 4 than to Gα * -GTPγ S (60, 61). A crystal structure of an RGS4-Gα i1 -GDP/AlF 4 complex also shows the Gα i1 to be in the transition-state-like configuration (41) . Several other RGS proteins also bind preferentially to the GDP/AlF 4 -bound form of their Gα targets (20, 22, 24, 69, 70) . The selectivity of GAPs for transition state-like structure extends to the monomeric GTP-binding proteins, which do not bind AlF − 4 under normal conditions but will do so when bound to their respective GAPs (44, 71) . Preferential binding to Gα-GDP/AlF 4 relative to Gα-GTPγ S is not universal. RGSZ1 binds Gα z -GTPγ S and Gα z -GDP/AlF 4 with similar affinity (72); the same is true for PLC-β1 and Gα q . In these cases, the GAP may accelerate conversion of Gα-GTP to Gα * -GTP. Such an effect would be predicted for effectors and may explain how PDEγ potentiates the GAP activity of RGS9.
The structure of the RGS4 complex with Gα i1 -GDP/AlF 4 (41), combined with mutational and kinetic data, has helped elucidate the mechanism of the GAP activity of RGS proteins. RGS proteins make a broad and discontinuous interface with Gα subunits. The interface includes each of the three switch regions of Gα, regions near the GTP binding site that undergo large conformational changes upon activation. Each switch is in direct contact with one or more of three interhelix turns of the RGS domain ( Figure 3 ). Tesmer et al (41) noted that the major change in Gα i1 upon binding RGS4 is decreased mobility of Switch II, as indicated by its decreased crystallographic temperature factor. This result led them to suggest that GAPs act by stabilizing Switch II in a catalytically active conformation through multiple interprotein contacts rather than by altering the position or orientation of one or more specific catalytic residues. This mechanism is probably general because key residues in the contact site of the RGS domain are conserved and the structure of free GAIP is nearly identical to that of RGS4 bound to Gα i1 -GDP/AlF 4 (42) .
The functional importance of residues on both sides of the RGS-Gα interface has been tested by mutational analysis, with the conclusion that RGS interface residues do not participate directly in catalyzing GTP hydrolysis, but rather stabilize the catalytic conformation of the Gα subunit. Mutation of single residues of RGS4 at or near the Gα interface can inhibit GAP activity profoundly (73), including several residues that are not well conserved among RGS domains; however, each position can tolerate some substitutions with slight inhibition of GAP activity. Even a highly conserved asparagine residue (Asn 128 in RGS4) that lies near the Gα active site can be multiply substituted with minor effects, primarily on affinity of RGS-Gα binding (48, 73, 74) . On the Gα side of the interface, mutation of residues in each of the three switch regions can diminish responsiveness to RGS proteins or alter selectivity among them (75) (76) (77) (78) , which again suggests that a relatively global conformational effect on Gα leads to accelerated hydrolysis.
The N-terminal helix of Gα is also important for its response to GAPs. Nterminal proteolysis (25-30 residues), phosphorylation (tested only for Gα z ), or palmitoylation (at Cys 3 ) decreases affinity for RGS proteins by ∼100-fold (49, 79, 80) ; myristoylation of the N-terminal glycine substantially increases affinity (79) . Because mutation of Ser 16 or Ser 27 in Gα z also reduces the basal GTP hydrolytic rate by 20-30% in addition to inhibiting response to GAPs (81) , the N-terminal region may be important for maintaining the structure of the nearby active site rather than for mediating GAP effects. Alternatively, it may contribute to the interface with the RGS protein, even though such contact was not detected in the crystal structure of the Gα i1 -RGS4 complex. In those crystals, the Gα i1 N terminus made a presumably artifactual crystal contact with the RGS4 molecule in the adjacent unit cell (41) . Additional regions of Gα and RGS protein outside the known molecular interface also contribute to GAP activity. These include both flanking regions of RGS4, which are important for interaction with G q but not G i (35) , and the α-helical domain of Gα t , which contributes to recognition of G t (82) . Both interactions probably enhance RGS-Gα affinity rather than altering the mechanism of GAP action.
Although mutagenesis efforts have mainly reinforced the original hypothesis of Tesmer et al (41) , three potentially useful mutants have also been produced. First, selection for pheromone-sensitive mutations in the yeast Gα subunit Gpa1p demonstrated that substituting a conserved glycine residue in Switch II makes Gα subunits essentially insensitive to GAP activity (77, 83) . Such GAP-resistant mutants in the G i and G q classes may facilitate cellular analysis of the physiological effects of GAPs. Second, mutation of Asp 229 in Gα s to Ser conferred limited GAP sensitivity (84) , which demonstrates that the G s class of Gα subunits is capable of responding to GAPs and encourages the search for endogenous G s GAPs. Third, studies of RGS mutants with diminished GAP activity that retain the ability to bind their Gα targets (48, 85) may lead to the design of efficacious dominant negative RGS proteins that may be used to disrupt GAP regulation in cells.
Regulatory Consequences of GAP Action
GAPs can promote rapid signal termination upon removal of an agonist, inhibit signaling during continued stimulation, or both. Controlling which effect predominates will determine the physiological function of a GAP, but using a GAP for only one of these functions demands coordinated regulation of the entire GTPase cycle.
Many RGS proteins act as inhibitors; Sst2p in yeast and EGL-10 and EAT-16 in C. elegans are good examples (17, 19, 86) . A GAP could also selectively suppress basal signaling by quenching spontaneously activated G protein without significantly inhibiting signaling in response to stimuli. In contrast to these inhibitory effects, GAPs can also accelerate signal termination without attenuating signal amplitude. In mice that lack RGS9, the principal RGS protein in photoreceptor cells, visual recovery after a light flash takes longer than in wild-type mice, but the amplitudes of signals elicited by short or long flashes are altered only slightly if at all (87) . Similarly, coexpression of RGS4 or RGS8 increases the speed with which a G protein-gated K + channel is regulated without significantly inhibiting the agonist-initiated signal (88) (89) (90) (91) (92) . Such control of signal kinetics is vital in cells such as neurons, which must turn on and off rapidly.
Kinetic studies of the G q GAP activity of PLC-β1 during steady-state, agoniststimulated signaling have begun to explain how a GAP can accelerate deactivation without attenuating signal amplitude. Both agonist-stimulated phospholipase activity and each of the intermediary steps in the GTPase cycle for this system can be measured with the use of reconstituted phospholipid vesicles that contain heterotrimeric G q , ml muscarinic cholinergic receptors, and the PLC substrate PIP 2 (47, 56) . In this system, PLC-β1 accelerates the rate of hydrolysis of Gα q -GTP from ∼0.01
, but stimulation of phospholipase activity by agonist in the presence of GTP remains substantial, 50-100-fold above basal. Signal amplitude is maintained because addition of PLC-β1 (or RGS4, also a G q GAP) increases the rate of receptor-catalyzed GDP/GTP exchange from ∼0.007 s −1 to ∼1.8 s −1 (47) . Experiments using m2 receptors, G i , and RGS4 produced similar behavior at steady-state (48) . This work led to the conclusion that, in the presence of agonist and GAP, rapid steady-state GTP hydrolysis is catalyzed principally by a complex of receptor, G protein, and GAP (47, 56) . This complex both exchanges GDP for GTP and hydrolyzes bound GTP quickly because all three components remain associated through many hydrolytic cycles (inner cycle in Figure 4 ). In the absence of a GAP, the receptor probably dissociates during the relatively long lifetime of the activated Gα-GTP complex because receptor affinity for GTP-bound Gα is relatively low. In this case, receptor reassociation with G protein becomes the rate-limiting step for the overall cycle (93) . In the presence of an active GAP, however, the receptor is still associated with the G protein after GTP hydrolysis and can then rapidly reactivate the G protein. By allowing the receptor to remain bound, a GAP indirectly facilitates rapid activation in addition to directly causing rapid deactivation. Signal strength is maintained while an agonist is present, but termination is fast when the agonist is removed.
Persistent association of receptor, G protein, and GAP during a prolonged stimulus may result simply from a combination of mutual affinity of the proteins and favorable kinetics (35, 47, 56) . This is probably the case for the proteoliposomes described above. Rapid cycling and maximal phospholipase activation are delayed for ≤90 s after addition of an agonist, suggesting that binding of receptor to G protein and subsequent recruitment of GAP are required to initiate formation of the Figure 4 GAPs kinetically regulate association of signaling proteins during the GTPase cycle. A GAP (G) can accelerate the overall GTPase cycle while maintaining a significant pool of activated Gα * -GTP by kinetically favoring continued association of agonist-liganded receptor (R) and Gα. Without a GAP, hydrolysis of Gα-bound GTP is slow (t 1/2 ∼ 10 s) (outer cycle). Receptor dissociates after Gα * -GTP is formed, such that the rate-limiting step both in reactivation and in the overall cycle is the reassociation of R with Gα-GDP to promote the next round of GDP/GTP exchange (as originally suggested by Levitzki (see 181) . In the presence of an active GAP (inner cycle), Gα * -GTP is hydrolyzed before the receptor dissociates. It can, therefore, promote rapid GDP/GTP exchange (t 1/2 < 500 ms) before the GAP and/or effector dissociates. Although steady-state GTPase activity is high, GDP/GTP exchange is fast enough to maintain significant Gα in the GTP-bound, activated state. Upon dissociation of agonist, however, signaling terminates promptly. If the proteins are not associated prior to addition of agonist, the transition from outer to inner cycle presumably occurs by the binding of a GAP to the transient R-Gα * -GTP complex (blue arrow, upper left) or by its activation. A GAP would be most likely to dissociate following GTP hydrolysis (blue arrow, lower right). Gβγ has been omitted for simplicity. complex (shaded arrow in Figure 4 , left). Although signal termination is fast upon removal of an agonist (t 1/2 < 3 s; perhaps as fast as GTP hydrolysis), the complex appears to remain associated for at least 10-20 s after the agonist dissociates (56) . In cells, however, RGS proteins or associated proteins may also act as scaffolds to organize receptor, G protein, and GAP (and, perhaps, other proteins) in a stable signaling complex even in the absence of stimulus (35, 88, 94, 95 ; see 96 for review of scaffolds). This would account for the finding that RGS4 and RGS8 actually accelerated the onset of signaling as well as its termination when signal output was measured using a Gβγ -gated K + channel as a monitor (88) (89) (90) 92) . Note that this general scheme also allows for the modulation of GAP activity (see below). Conversion from a slow-response regimen to a faster pattern of responses can thus be controlled by the concerted regulation of receptor, GAP, and their association with G protein.
G PROTEIN EFFECTORS AS GAPS
The first recognized G protein GAP was the Gα-regulated effector protein PLC-β1 (11) . Only a few other G protein effectors are known to have GAP activity: p115RhoGEF, a G 13 -regulated effector and G 13 GAP (15); possibly some isoforms of adenylyl cyclase (97); and, conceptually at least, the γ subunit of retinal cyclic GMP PDE, which potentiates the G t GAP activity of RGS9 (12, 13, 98, 99) . The reason that GAP activity evolved in effector proteins remains speculative. RGS proteins are generally assumed not to have effector functions, but regulation of their GAP activity certainly confers a signaling function either in feedback or crosstalk circuits. For example, genetic evidence suggests that EAT-16, a G q GAP found in neurons of C. elegans, is regulated by Gα o (86) . In addition, the signaling modules outside the RGS domain may generate their own signals (e.g. the PP2A-like domain of axin) or regulate other proteins to which they bind. Activities of these flanking domains and their potential control by G proteins largely remain to be elucidated. The finding that the RGS domains of GRK2 and 3 bind Gα q , display modest G q GAP activity (37) , and are themselves regulated by Gβγ (100, 101) is a good example of how such signaling via RGS proteins may take place.
PLC-β β
The PLC-β family of PIP 2 -selective phospholipases are the major recognized effectors for the G q class in addition to being highly G q -selective GAPs. PLC-β1 binds GTP-bound Gα q with a K d estimated to be ∼2 nM and accelerates hydrolysis of Gα q -bound GTP from 0.01 s −1 to 15 s −1 at 30
• C, ∼1000-fold (11, 47, 56) . Although comparably detailed measurements are not available for other PLC-β isoforms and G q family members, all the PLC-βs tested are G q GAPs. The GAP activity of PLC-β4 is about equal to that of PLC-β1, the maximal activity of PLC-β2 is approximately that of PLC-β1 but its EC 50 is ∼40 times higher, and PLC-β3 appears to be a somewhat weaker GAP than is PLC-β1 (G Biddlecome, S Mukhopadhyay, EM Ross, unpublished data). The Drosophila visual PLC-β NorpA appears to act as a GAP for the endogenous G q in photoreceptor membranes (102; B Cook & Z Selinger, unpublished data). In addition, G q , G 11 , and G 16 (all Gq class) are about equally sensitive to the GAP activity of PLC-β1 (11; unpublished data). Unlike the RGS proteins, PLC-β1 is strictly selective for the G q class. We have been unable to detect any GAP activity of PLC-β1 toward G i , G o , G z , or G s .
PLC-βs bear no obvious structural relationship to the RGS proteins, but, by using mutation and proteolysis, it has been possible to map domains important for interaction with Gα q . PLC-βs share a catalytic core with the PLC-γ s and PLC-δs, but they are notable for a C-terminal extension of ∼40 kDa (103) (104) (105) . Removal of the C-terminal region blocks the ability of the PLC-β to respond to activated G q (106, 107) or to act as G q GAPs, as do several deletion mutations in this region (O Ilkaeva & RH Paulssen, unpublished data). Isolated fragments of the C terminal domain as small as 18 kDa display G q GAP activity, but their diminished affinity (100 nM vs 2 nM for intact PLC-β1) and complex interactions suggest that intact PLC-β1 may have more than one contact site for Gα q (40, 108) . Nevertheless, expression of the C-terminal domain in cells has been reported to inhibit G q -mediated signaling, which suggests at least that it sequesters cellular Gα q (107, 109) .
Because the GAP activity of PLC-β1 is similar in many ways to that of RGS proteins, it is tempting to speculate that the PLC-βs evolved from the fusion of genes for an RGS protein and a PLC-δ, which lacks the C-terminal GAP domain and has no GAP activity. Both PLC-δ and RGS proteins are found in the fungi, which lack PLC-βs. Weak similarity can be found in alignments of the amino acid sequences of PLC-β GAP domains and RGS domains, but any phylogenetic relationship between RGS proteins and PLC-βs remains uncertain.
Rho GEFs
Genetic evidence indicates that activation of the monomeric GTP-binding protein Rho by GPCRs is probably mediated by G 13 (110) (111) (112) (113) , and an N-terminal regulatory domain of a family of Rho-selective GTP exchange factors (GEFs) is slightly similar in sequence to the RGS domain. This information led Hart et al (14) and Kozasa et al (15) to discover both that the Rho GEF activity of p115 is stimulated by Gα 13 (but not Gα 12 ) and that p115 is an active and selective Gα 13 GAP (and a much weaker Gα 12 GAP). The hydrolysis by p115 of GTP bound to Gα 13 was accelerated at least 10-fold in a single-turnover assay. Although GAP activity did not obviously saturate even at 100 nM p115, competitive inhibition by GDP/AlF 4 -bound Gα 13 suggests that its K d for p115 is ∼3 nM. The GAP p115 is highly selective for the G 12 class of Gα subunits, reminiscent of the selective interaction of PLC-β and G q . It was inactive as a GAP toward members of the G i , G q , and G s classes. A related RhoGEF displayed similar selectivity for Gα 12/13 in binding assays (114) . Although Gα 12 was not a good GAP substrate for p115 and did not stimulate RhoGEF activity, GDP/AlF 4 -bound Gα 12 potently inhibited the G 13 GAP activity of p115 (14, 15) . Gα 12 may thus be a true antagonist of the Gα 13 -p115-Rho pathway.
The N-terminal RGL domain of p115 displayed G 13 GAP activity when expressed separately, supporting the validity of its weak sequence similarity to the RGS domain. As mentioned for PLC-β, the p115RhoGEFs thus appear to have arisen from the fusion of genes for an otherwise regulated exchange factor and a primordial RGS domain. Such a history implies not just that GAP activity could be conferred in this way, but that regulation by Gα subunits may have arisen by first using a RGL domain for Gα binding, followed by the evolution of regulatory responsiveness.
Cyclic GMP Phosphodiesterase
Although not a GAP itself, the γ subunit of the cyclic GMP PDE from vertebrate photoreceptor cells both forms the Gα t binding site on the PDE αβγ 2 heterotetramer and potentiates the GAP activity of RGS9/Gβ5. This "co-GAP" activity was discovered because PDEγ increased the rate of hydrolysis of GTP added to washed photoreceptor membranes to which a small amount of G t had been restored (12) . Because RGS9/Gβ5 remained membrane bound, it was able to combine with rhodopsin and G t to reveal this activity (13, 98, (115) (116) (117) . The co-GAP activity of PDEγ is crucial for appropriate termination of the response to light: Mice that express a mutant PDEγ that interacts poorly with G t display a prolonged recovery after a light flash (99), a phenotype similar to that of the loss of RGS9 (87) . The structural basis of the co-GAP effect of PDEγ is unknown. PDEγ selectively potentiates the GAP activity of RGS9 (and perhaps other R7 subfamily members) (13), but slightly inhibits the GAP activity of RGS4, RGS16, RGS6, and GAIP (42a; 117a,b). Evolutionary relationships led Sowa et al (42a) to speculate that PDEγ binds directly to RGS9, but McEntaffer et al (117c) found no evidence of high affinity binding of the isolated proteins.
Why Should Effector Proteins Be GAPs?
Why should an effector protein promote the deactivation of the Gα that regulates it? The energetics of the GTPase reaction does not demand that an effector, defined as a preferential ligand of Gα * -GTP relative to Gα-GDP (Scheme II), either accelerate or inhibit GTP hydrolysis. One function of intrinsic GAP activity is to allow each effector of a single G protein to display distinctive response kinetics and dynamics. For example, different PLC-β isoforms may respond differently to the same G q -linked receptor based on their different GAP activities. In general, intrinsic GAP activity allows an effector to respond rapidly to a stimulus and its removal but maintain high signal throughput while the stimulus is present (56; see Figure 4 ). Viewed slightly differently, GAP activity poises an effector to respond to an inhibitory input, perhaps via a distinct, but associated, RGS protein. Having GAP activity reside in the effector also allows a newly activated G protein to remain active until it encounters the effector, whereupon it would either deactivate quickly if no agonist were present or, in the continued presence of agonist, enter a rapid and controlled GTPase cycle and maintain its activity (Figure 4) . This mechanism will suppress basal (background) signal output without sacrificing the maximal signaling capacity of the pathway. Last, GAP activity allows an effector to enhance the selectivity of its upstream G protein among different receptors. If a receptor is to activate an effector with intrinsic GAP activity, it must bind the G protein target tightly enough to remain associated throughout multiple GTPase cycles (Figure 4) . A receptor that can activate a given G protein but that binds with low affinity would be unable to maintain activation if the effector molecule were a GAP. Such a receptor could use that G protein to convey its signal to an effector without GAP activity but could not signal to an effector that is a GAP.
GAPS AND SIGNAL PATHWAY SPECIFICITY
The ability of RGS proteins to select among Gα substrates is clearly necessary for their actions as signal regulators. Selectivity of an RGS protein for a G protein target may be manifest merely as appropriate modulation of signal amplitude from a receptor. If a receptor regulates multiple G proteins, however, then selective modulation of one Gα by an RGS protein can qualitatively change the nature of output from a single receptor. RGS proteins can be highly specific for Gα targets. EGL-10 is highly selective for G o over G q in C. elegans neurons (19, 86) , and neither yeast RGS protein (Sst2p or Rgs2p) can complement a deficiency of the other (118) . Similarly, p115RhoGEF acts only on G 12 class α subunits, and PLC-β acts only on G q class members. It has been more difficult to delineate the selectivity of most of the mammalian RGS proteins among their potential G i and G q class targets. Some selectivity is conferred by restrictive patterns of cellular expression (e.g. RGS9 and Gα t in retinal photoreceptor cells), but little is known about selective RGS-Gα interactions in a less-specialized cell that expresses multiple RGS proteins and Gα subunits. Investigators have tried to identify and evaluate physiologic targets of RGS proteins by measuring selectivity in GAP assays and relative attenuation of signaling upon transfection or microinjection. Results from these approaches often agree, but observed selectivity can also be assay-dependent; neither approach is certain to reflect the action of an RGS protein in its natural environment.
Selectivity In Vitro
The selectivity of RGS proteins among potential Gα targets can be evaluated in vitro by comparing their behaviors in single-turnover GAP assays (K m , k cat ), their abilities to compete with substrate in such assays (K i ), or their binding affinities according to coprecipitation or coadsorption assays. Relative activities of different GAPs can also be compared by monitoring elevation of agonist-stimulated GTPase activity (see 50 for description of GAP assays formats and analysis). RGS and RGL GAPs have displayed varied patterns of selectivity in such assays. For example, GAIP displays GAP activity toward both G i and G q class substrates. It is relatively nonselective among G i class members (20, 49, 119) ; it is a weak GAP for Gα q [low K m but low relative stimulation of hydrolysis (49) ; interacts poorly in yeast-twohybrid assay]. In contrast, RGSZ1 and RET-RGS1, which are closely related to GAIP by sequence and which are equally active as Gα z -GAPs, are highly selective for Gα z relative to other G i class members and display very low GAP activity toward Gα q (49) . Similarly, RGS6 and RGS7 (in complex with Gβ5; see below) are selective for Gα o relative to other G i class members (166) . The selectivity of RGS2 for G q over G i class Gα subunits is more complex: Selectivity for G q is high in transfected cells (120, 121) and in single-turnover assays (55) , but RGS2 is an active G i GAP in the steady-state assay (55) . Although the receptor-coupled, steady-state assay appears more physiologically relevant than the single-turnover assay and allows quantitative comparison of RGS proteins and Gα substrates over a wide range of activities, its greater sensitivity may detect nonphysiological activities. For many other RGS proteins, selectivity in vitro has not convincingly indicated their cellular preferences (when such preferences are known).
Amino-acid residues on RGS proteins and Gα subunits that determine selectivity have been identified in a few cases, but selectivity apparently involves multiple interactions throughout the RGS-Gα interface. For example, the selectivity of RGS2 for Gα q is largely conferred by three Gα q residues, Cys 106 , Asn
184
, and Glu
191
, which apparently reduce affinity for Gα i by steric hindrance (121) . RGS16 can accelerate GTP hydrolysis by the D229S mutant of Gα s (substitution by the cognate residue of Gα i ), although wild type Gα s neither binds RGS16 nor is a substrate (84) . Mutations at this site can also alter the selectivity of RGS-GAIP among Gα i isoforms (76) . RGS4 N128F becomes more selective for Gα q relative to Gα i ; mutation of Lys 180 in Gα i1 to proline, the homologous residue in Gα q , restores some of the interaction with the mutant RGS4 (48) . The α-helical domain of Gα t is also important for its selective interaction with RGS9 (82).
RGS-Gα Selectivity in Cells
Genetic complementation assays in yeast provided the first tests of RGS function in cells, but also demonstrated that exogenous RGS proteins, when overexpressed, can act promiscuously on nonphysiologic substrates (70, 122) . Similarly, transfection studies in mammalian cells have shown that almost any RGS protein can attenuate signals mediated by G i and/or G q . Nonetheless, evidence of regulatory specificity has emerged from such studies. As mentioned above, RGS2 displays cellular selectivity for G q over G i targets (120, 121, 123) . In transfected CHO cells, RGS16 inhibited activation of p38 MAP kinase by platelet activating factor more effectively than platelet activating factor-initiated activation of ERK2; RGS1 displayed the opposite pattern of selectivity (124) . This behavior presumably reflects differential targeting of G q or G i by these RGS proteins even though G i and G q are apparently activated by the same platelet activating factor receptor (see also 123). The best evidence for Gα-selective action of RGS proteins will emerge from studies of natural cells whose endogenous signaling pathways can be evaluated without overexpression of transfected genes. An early example comes from studies of Ca 2+ channel regulation in dorsal root ganglion cells (125) . In this study, α 2 -adrenergic activation of Gα i and Gα o was enhanced by antibodies against RGS4 and GAIP, respectively, whereas antibodies against RGS2, RGS12, and RGS10 did not alter their signaling (125) . Microinjection of the RGS proteins confirmed these results.
RGS proteins can thus alter signal inputs from single or multiple receptors and target individual downstream signaling pathways.
Receptor-Selective Activities of RGS Proteins
RGS proteins can also selectively regulate different receptors that use the same G protein. In pancreatic acinar cells, RGS4 blocked G q -mediated PLC-β activation and consequent Ca 2+ signaling initiated by m3 muscarinic cholinergic receptors, cholecystokinin receptors, or bombesin receptors, all of which signal through G q class Gα subunits (126) . However, inhibition of m3 muscarinic stimulation was ∼30-fold more potent than inhibition of cholecystokinin action, and stimulation by bombesin was intermediately sensitive. RGS1 and RGS16 were 1000-and 100-fold selective, respectively, in inhibiting muscarinic Ca 2+ signaling action relative to cholecystokinin. Receptor selectivity did not reflect differential use of G q class Gα subunits by each receptor because the same pattern of inhibition was observed in cells from wild-type and several single and double G q -class knockout mice (126) . The receptor-selective action of RGS4 requires the concerted action of both the N-and C-terminal flanking regions and the RGS domain; the RGS domain alone inhibited signaling from each receptor equally and displayed 10,000-fold lower potency (35) . It is unknown whether selectivity among receptors is conferred by direct receptor-RGS4 binding, by subcellular colocalization, or by distinct kinetic properties of the receptors. In the case of RGS12, an N-terminal PDZ domain binds specific chemokine receptors (94), but receptor-RGS4 binding has not been observed.
REGULATION OF RGS PROTEINS
The ubiquity and diverse activities of G protein GAPs virtually demand their regulation. Cellular levels of many RGS mRNAs are modulated by developmental factors and more acute stimuli (see list in 27). The activities of RGS proteins are modulated by covalent modification and modification of their Gα substrates, by alteration of their subcellular localization, and by interaction with multiple, newly discovered binding partners.
Regulation of RGS Protein Synthesis and Accumulation
Even before the yeast RGS protein Sst2p was shown to be a GAP for the G protein Gpa1p, its expression was found to be induced at the transcriptional level by the mating factor that initiates Gpa1p signaling (17) . Because Sst2p helps overcome cell cycle arrest induced by mating factor, Sst2 induction provided the first indication that RGS proteins can act as negative feedback regulators of the pathways that induce their expression. Similarly, the mammalian proteins RGS1 and RGS2 were identified as genes that are induced by activators of B-lymphocytes and monocytes.
The mRNAs for RGS proteins are now known to be regulated by a variety of stimuli; many of these experiments have been recently reviewed (27, 32) . As expected for proteins that regulate G protein signaling, almost all RGS genes are expressed in the brain. Several are restricted to discrete regions (27, 128, 129) , and many are regulated by neurotransmitters, trophic agents, and second messengers (55, (130) (131) (132) (133) . It is not yet known how much of this regulation is feedback from downstream signals and how much represents inputs from distinct pathways. Many RGS mRNAs are also regulated in non-neural cells and tissues. They include RGS3 and RGS4 in heart (134), GAIP and RGS16 in colon adenocarcinoma cells (135, 136) , RGS2 in β-TC3 insulinoma cells (137) , RGS2 and RGS16 in T-lymphocytes (123) , and RGS16 in ventricular cardiomyocytes (138) and liver (K Yu & T Wilkie, unpublished data). Regulatory inputs are diverse. They include fibroblast growth factor and pressure overload in the heart, interleukins and mitogens in T cells, the tumor suppressor p53, and glucose-dependent insulinotropic peptide.
Regulation of the cellular concentrations of RGS proteins post-transcriptionally is also important, but the natural cellular concentrations of RGS proteins have rarely been measured because of the low levels at which they are usually expressed. Although translational regulation of RGS protein accumulation has not yet been studied, the cellular concentrations of RGS proteins are, in some cases, modulated by regulating their proteolysis. The half-life of Sst2p in yeast is increased by phosphorylation by the MAP kinase Fus3p (45) . The phosphorylation site, in the 4/5 loop of the RGS domain, is near two PEST motifs, which mark rapidly degraded proteins. Regulation of RGS7 protein stability is particularly striking. RGS7 is completely degraded by ubiquitin-directed proteolysis within 60 min after addition of cycloheximide, but it is protected by TNFα-initiated activation of the stress-activated MAP kinase p38 (133) . The TNFα-responsive phosphorylation site is in a Ser/Thr-rich sequence unique to RGS7 that lies just N-terminal of the Gγ -like (GGL) and RGS domains. TNFα-induced stabilization of RGS7 protein is apparently significant in vivo because injection of lipopolysaccharide increases RGS7 levels in brains of wild type mice but causes a much smaller effect in brains of mice that lack functional TNF receptors. Stabilization of RGS7 may thus contribute to some of the neurological effects of sepsis (133) . RGS7 in kidney is protected from rapid proteolysis by binding to polycystin (139), a protein frequently mutated in polycystic kidney disease. Because RGS7, polycystin, and Gβ5 are expressed coincidently in developing renal tubules, polycystin may modulate the regulatory activities of RGS7/Gβ5 in addition to inhibiting its degradation.
Covalent Modification of RGS Proteins and Their Gα Targets
The activities of RGS proteins are regulated by covalent modification of the RGS proteins themselves and of their Gα substrates. Regulation of the RGS protein turnover (see above) and of the regulatory behavior of PLC-β isoforms by phosphorylation (140, 141) has now been noted in several cell types. The G z GAP activity of RGS proteins is also regulated by phosphorylation near the N terminus of Gα z . Gα z , a member of the G i class that is expressed at low levels in the brain and a few other secretory tissues, is phosphorylated at two nearby sites by protein kinase C and at one of the two sites by PAK, which potentially allows the regulation of G z by several signaling pathways (81) . Phosphorylation at either site inhibits GAP activity. The extent of the inhibition can exceed 90%, but it varies among RGS proteins and according to which site is phosphorylated (49, 80, 81) . Gα z is naturally phosphorylated by PKC in platelets and elsewhere (142, 143) , and can be phosphorylated by PAK in 293 cells in response to recombinant activated Rac1 (81) . Gα 12 is also phosphorylated near its N terminus by PKC (144) , and it will be of interest to find whether phosphorylation alters its interactions with p115RhoGEF.
GAP activity is modulated by the reversible palmitoylation both of RGS proteins and of their Gα targets. Several RGS proteins are palmitoylated near their N termini and at a highly conserved cysteine residue in the RGS domain. N-terminal palmitoylation, at a pair of cysteine residues in the R4 subfamily (145, 146) and at a cysteine string in the RZ subfamily (119) , is implicated in subcellular localization and membrane association, although details of the relationship are unclear. Palmitoylation in the RGS domain strongly inhibits GAP activity when measured in detergent solution in a single-turnover assay, but can potentiate GAP activity in receptor-G protein proteoliposomes (147) . This bidirectional control of GAP activity depends in part on which RGS protein is studied. It is not known whether RGS protein palmitoylation is regulated in cells, but in RGS4-expressed Sf9 cells palmitate turns over at both sites on the 10-60 min time scale.
Gα subunits are also reversibly palmitoylated at a conserved N-terminal cysteine residue (151) (152) (153) . Gα palmitoylation inhibits responsiveness to the GAP activity of RGS proteins, primarily by increasing K m (79) . Inhibition can be nearly total, but the extent of inhibition in one report correlated with the activity of the RGS protein on the particular Gα-GTP substrate. Thus, the activity of RGSZ1 on Gα z was inhibited >90% by Gα z palmitoylation, but other RGS-Gα pairs that interacted less productively or with lower affinity were inhibited less. Many studies of palmitoylation-deficient mutants have linked Gα palmitoylation both to signaling activity and to the membrane localization, but the diversity of these results has not allowed generalization that supports or refutes the physiologic importance of the inhibition of GAP activity (49, 80, 81) .
Cellular Binding Partners of RGS Proteins
RGS proteins can bind a wide variety of other cellular proteins in addition to Gα subunits. These interactions may modulate GAP activity or subcellular localization, or may allow RGS proteins to regulate novel signaling pathways. Physiological roles for most of these interactions are not known, but they are under intense study. Specific binding partners and interaction domains appear to correlate within RGS subfamilies; these are listed in Figure 1 . In addition to the cysteine strings, N-terminal amphipathic helices and GGL-domains (described separately), DEP, PTB, PDZ, Rap binding, and LOCO domains have been identified by sequence homology and/or yeast two-hybrid screens (94; 154a,b) . PDZ-binding motifs were discovered on two RGS proteins, RGS12 and GAIP (94, 154c) . The PDZ-domain protein GIPC (for GAIP interacting protein, C terminus) may orient GAIP within a multiprotein complex to regulate vesicular trafficking (154c) . Lipids may also regulate RGS activity. For example, the GAP activity of most RGS proteins is inhibited by PIP 3 but not other phosphoinositides, and PIP 3 -responsive feedback regulation of RGS GAP activity.
RGS proteins themselves may provide scaffold functions to regulate signaling apart from or in addition to, their GAP activity. Axin, the prototype for the RA subfamily, provides a perhaps extreme example of the interrelated protein binding activities of RGS proteins. Axin, a component of the wnt developmental signaling pathway, is not known to have GAP activity or to bind to a Gα. It appears instead to be a scaffolding protein. Its RGS domain binds adenomatous polyposis coli protein (154); they together control wnt-dependent nuclear translocation of the transcription factor β-catenin (155, 156) . In the absence of wnt, axin binds both β-catenin and a glycogen synthase kinase at sites outside the RGS domain and promotes glycogen synthase kinase-dependent phosphorylation of β-catenin. Phosphorylation targets β-catenin for degradation (155) . If the RGS domain of axin is removed, the resulting mutant still binds β-catenin but prevents its phosphorylation, thus mimicking wnt signaling by stabilizing β-catenin (157) . Axin has also been reported to bind MEKK1 in yet another region (158) . Each domain of axin thus provides scaffolding sites for the regulated interaction of multiple signaling molecules in an important developmental pathway.
REGULATION BY Gβ βγ γ SUBUNITS AND A GGL DOMAIN
Three recent observations point to novel and important effects of Gβγ subunits and/or Gβ5 on the action of G protein GAPs; only some relate to their previously known activities (see 159 for review of Gβγ regulatory functions). Gβγ binds to Gα negatively cooperatively with respect to GTP. Activation by GTP therefore displaces Gβγ from Gα (or at least alters its mode of binding) such that Gβγ can regulate multiple effector proteins, most notably some isoforms of adenylyl cyclase, K + channels, PLC-β, and protein and lipid kinases. Conversely, Gβγ binds Gα positively cooperatively with respect to GDP, thereby stabilizing GDP binding and suppressing spontaneous, receptor-independent activation. In addition, Gβγ helps anchor Gα to the membrane and (partly thereby) is essentially required for receptor-catalyzed GDP/GTP exchange.
Gβ βγ γ Inhibits GAP Activity in Single-Turnover Assays
Gβγ inhibits the GAP activities of both RGS proteins and PLC-β in solution-based, single-turnover assays (49, 72, 160) . Inhibition has been observed for PLC-β1 and several RGS proteins (RGS4, RGSZ1, GAIP, and RGS10), and for several different Gα substrates (Gα i , Gα q , Gα z , Gα o ). Inhibition, which appears primarily as an increase in K m of >10-fold, can exceed 80%. IC 50 values vary from 50-400 nM. Crystal structures indicate that the binding sites on Gα i for RGS4 and Gβγ overlap (41, 161) , but inhibition of GAP activity by Gβγ varies among different GAPs in ways inconsistent with simple competition (49, 81) . It is likely that inhibition of GAP activity by Gβγ reflects its direct interaction with both the Gα substrate and the GAP itself.
The inhibition of GAP activity by Gβγ observed in single-turnover assays seems inconsistent with the high GAP activities observed in steady-state GAP assays in which Gβγ is present at high local concentrations (47, 48, 56) . These assays use receptor, heterotrimeric G protein, and GAP coreconstituted into unilamellar phospholipid vesicles, such that the calculated concentration of Gβγ at the vesicle surface is ≥20 µM (50), well above the IC 50 determined in solution. The apparent disagreement between these results may be reconciled by hypothesizing some special orientational or permissive role of the lipid bilayer in the steadystate assay, but the problem is probably more fundamental, as discussed below. This paradox is reminiscent of the observation that Gβγ suppresses GDP/GTP exchange in isolation but is essentially required for receptor-catalyzed exchange (159); both observations suggest potentially biphasic regulation by Gβγ in cells.
The GGL Domain: Selective Association of RGS Proteins with Gβ β5
A major clue to the role of Gβγ in RGS action came from the finding by Snow et al (162) that several RGS proteins (RGS6, 7, 9, 11) contain a domain similar in sequence to Gγ subunits, referred to as a GGL domain. They found that RGS11 selectively binds Gβ5, a Gβ isoform that is found primarily in neural tissue and whose sequence diverges notably from those of Gβ1-4 (163). RGS11 bound Gβ5 when the proteins were either translated together in vitro or when the two cDNAs were cotransfected into Cos cells. Gβ5 also bound to an independently expressed GGL domain from RGS11; deletion of the GGL domain from RGS11 eliminated binding. Gβ5 mRNA is alternatively spliced to yield a partially soluble short form (Gβ5S) and a mostly membrane-associated long form (Gβ5L); both bound to RGS11 and its GGL domain (162) . The physiologic validity of GGL-Gβ5 binding was further substantiated by the observations that endogenous Gβ5 copurifies with RGS7 from retina (164) and with RGS6 and RGS7 from brain (164a) , that recombinant RGS11 and Gβ5 copurify from Sf9 cells (162) , and that a mutant mouse whose RGS9 genes are disrupted does not accumulate Gβ5L in the retina (87) .
The complex of RGS11 and Gβ5 displays GAP activity in vitro, with preference for Gα o as substrate (162) . A complex of RGS9 and Gβ5L is evidently the principal G t GAP in photoreceptor cells (13, 87, 165) . RGS6 and RGS7 are also selective Gα o GAPs when combined with Gβ5 (166) . The GAP activity displayed by the complex of RGS9 and Gβ5 can support agonist-stimulated steady-state GTPase activity when assayed in phospholipid vesicles coreconstituted with m2 muscarinic cholinergic receptor and Gα o (but without added Gβγ ). This finding suggests that Gβ5 and the GGL domain can functionally replace a conventional Gβγ in promoting receptor-Gα coupling (TK Harden & AG Gilman, unpublished) .
The GGL domain is not required for G protein GAP activity in vitro (13, 162) , however, and there is one report that Gβ5 inhibits the binding of RGS7 to Gα o . This result, which was obtained using tracer amounts of in vitro translated proteins and which was not accompanied by data on RGS function, seems to be in conflict with others (87, 162, 165) . Although it may be incorrect, it is consistent with the inhibition of GAP activity of other RGS proteins by Gβγ dimers discussed above and may reflect a potential bidirectional action of Gβ that depends on assay conditions.
The detailed function of the GGL domain and binding to Gβ5 have been hard to ascertain because it has not been possible to isolate useful amounts either of a GGL-containing RGS protein without Gβ5 or of Gβ5 alone. Both proteins probably associate shortly after translation, and each is crucial to the stability or initial folding of the other. For example, retinas of RGS9 −/− mice do not contain detectable Gβ5L despite the presence of a normal amount of its mRNA (87) . Although Gβ5 does bind to other Gγ subunits upon overexpression of both, affinity is low and accumulation of Gβ5γ dimers is inefficient (168) . Two mutations in GGL domains have been reported to alter their selectivity among Gγ subunits (169, 170 ); interaction appears to be determined by multiple contacts between the extended structure of GGL domain (or Gγ ) and the face of the Gβ disc (161, 171) . Although the complex of Gβ5 and either RGS6 or RGS7 mediates receptor-Gα interactions, neither complex stimulates type II adenylyl cyclase, inhibits type I adenylyl cyclase, or stimulates PLC-β2 (166) . Conventional Gβγ dimers (Gβ1-4) display each of these activities. The inability of the RGS-Gβ5 complexes to regulate these effector proteins may reflect intrinsic differences between the Gβ5-GGL complex and other Gβγ dimers, as well as an inhibitory effect of the attached RGS domain.
A Model for Gβ β-RGS Interactions: Evidence from Gβ βγ γ -Gated K + + Channels
The implicit contradiction between the inhibition of GAP activity by Gβγ in solution and the high receptor-promoted GTPase activity observed in membranes that contain Gβγ can potentially be explained if attachment of the proteins to a phospholipid bilayer blocks inhibition by Gβγ . A more interesting proposal is that the association of Gβγ with Gα, receptor, or GAP is altered during receptorstimulated GTPase turnover to make Gβγ an active regulatory participant in the GTPase cycle. Examples of such behavior include the participation of Gβ5 and the GGL domain in receptor-stimulated steady-state GTP hydrolysis (TK Harden & AG Gilman, unpublished) and the Gβγ -mediated activation of K + channels. Effects of RGS proteins on Gβγ -mediated regulation of inwardly rectifying K + channels (Gβγ -gated K + channels or GIRKs) have provided insight into RGS-Gβγ signaling interactions by showing that GAPs can enhance the temporal acuity of signaling without diminishing signal amplitude. GIRKs are activated (opened) by Gβγ subunits (usually from heterotrimeric G i ; see 159, 172) , but their kinetics of activation and deactivation are often sluggish when they are overexpressed in heterologous cells. Most markedly, channel closing is quite slow upon removal of agonist, similar in rate to the hydrolysis of GTP by isolated Gα subunits. Doupnik et al (88) and Saitoh et al (89) found that several RGS proteins increased the speed at which GIRK channels close when an agonist is removed, consistent with continuously accelerated hydrolysis of Gα i -bound GTP and consequently rapid sequestration of Gβγ . Surprisingly, RGS proteins attenuated the agoniststimulated, steady-state K + current only slightly, even though the deactivation rate was increased >10-fold (see also 90). Such accelerated deactivation should have inhibited the K + current by 90% unless receptor-catalyzed binding was accelerated commensurately. The rate of channel activation upon addition of agonist was increased, although only about twofold (88) , which suggests that GDP/GTP exchange was much faster during continued stimulation than at its outset. Because RGS7/Gβ5 and RGS9/Gβ5 can mediate rapid activation and deactivation of GIRK channels with little attenuation of amplitude (172a), it is likely that all the relevant proteins-receptor, Gα, RGS/Gβ5, and channel-remain associated in a signal transducing complex over an extended time scale.
Accelerated deactivation upon removal of agonist without significant loss of signal amplitude is consistent with the idea that GAP activity allows formation of a signaling complex of receptor, Gα, and GAP that rapidly binds and hydrolyzes GTP (26, 56, 88) (Figure 4) . However, this model does not explain the increase in the initial activation rate that is observed in the presence of RGS proteins (90) . In addition to their GAP activities, the RGS proteins may act as scaffolds to maintain association of receptor and G protein prior to receptor activation. They may also decrease the affinity of Gα subunits for Gβγ and thus increase the availability of Gβγ upon activation (90, 91, 173) . In support of this idea, Bünemann & Hosey (173) reported that RGS3 and RGS4 by themselves produce modest Gβγ -mediated activation of GIRKs. Facilitated release of Gβγ by RGS protein and the inhibition of RGS GAP activity by Gβγ (see above) may both be explained as negatively cooperative binding of RGS protein and Gβγ to Gα, such that each decreases the affinity of Gα for the other. This conjecture clearly remains to be tested.
The behavior of Gβγ -regulated GIRK channels does not explain how Gβγ can inhibit a single round of GTP hydrolysis in solution without substantially inhibiting steady-state GTPase activity in membranes. The answer to the latter question may be that RGS proteins and Gβγ interact positively rather than negatively when both proteins and Gα are bound to receptor in the presence of agonist. Both the positive and negative interaction could operate using either a distinct Gβγ dimer or the combination of a GGL domain and Gβ5, as suggested by the ability of a GGL/Gβ5 complex to replace conventional Gβγ in both control of GIRK channels and in mediating rapid GTP hydrolysis (172a; TK Harden & AG Gilman, unpublished). Because GGL/Gβ5 performs these functions while covalently bound to the RGS domain, we suggest that an RGS protein may not drive actual dissociation from Gα but rather the reorientation of the various domains such that they, with receptor, could mediate rapid GDP/GTP exchange. In the case of the GIRKs, it is likely that Gβγ does not completely dissociate from activated Gα i in order to promote channel opening, but that the Gα-Gβγ interface changes during Gα activation to allow bound Gβγ to stimulate channel opening (174) (175) (176) (177) .
CELLULAR REGULATION BY RGS PROTEINS: A C. Elegans Model
What is known about the roles of endogenous RGS proteins in cellular signaling comes primarily from genetic studies in mice, worms, and fungi. RGS9 accelerates termination of the mammalian photoresponse following stimulation by light, which suggests that its major effect is to regulate signaling kinetics rather than to act as an inhibitor (87) . In contrast, RGS proteins in Saccharomyces and Neurospora (Sst2p and RGS2; FlbA) apparently act as inhibitors, with Sst2p mediating a feedback loop. Perhaps the most provocative studies of RGS physiology come from genetic analysis of RGS regulation of G o and G q pathways in C. elegans. Pioneering studies identified roles for RGS proteins in motility and egg laying, which are regulated by the opposing activities of Gα o and Gα q and the RGS proteins, EGL-10 and EAT-16. Subsequent genetic analysis of worms with either gain-of-function or loss-of-function alleles in these Gα and RGS genes indicates an unexpected role for EAT-16 as an effector protein in the serotonin-stimulated G o signaling pathway.
Motility and egg laying are easily scored and are therefore well-studied behaviors in worms. Gα o deficiency causes hyperkinesis; expression of activated Gα o causes sluggish locomotion, foraging and feeding, and delayed egg laying (19, 178-180, 180a,b) . EGL-10 is coexpressed with Gα o in the relevant cells and is probably its attendant RGS protein. As expected for an inhibitor of G o signaling, deletion of the RGS gene Egl-10 caused a hypokinetic behavior similar to that caused by activated Gα o ; EGL-10 was only effective in the presence of wild-type Gα o . Thus, the intensity of Gα o signaling was elevated by increasing the copy number of the wild-type Gα o gene, by expressing a constitutively active allele of goa- 1[Q205L] that is presumably refractory to GAP activity, or by reducing the activity of EGL-10.
The Gα q gene, Egl-30, also opposes Gα o -mediated effects on motility and egg laying. The biochemical mechanism of antagonism between G o -and G q -signaling remained enigmatic until Hajdu-Cronin et al (86) found that the phenotype of a constitutively active Gα o mutant is suppressed by the loss of EAT-16, an RGS protein of the R7 family. The behavior of EAT-16 suggested that it acts as a G q GAP, and expression of EAT-16 in Cos cells inhibited m1 muscarinic stimulation of G q -mediated inositol phosphate production. Genetic analysis suggested that Gα o enhances the inhibitory activity of EAT-16 on G q signaling; EAT-16 may be an effector or downstream target of the G o pathway. Because EAT-16 contains a GGL domain, it is tempting to speculate that the serotonin receptor may act through a complex of Gα o , the EAT-16 GGL domain, and Gβ2 (the C. elegans homologue of mammalian Gβ5). In this case, G o may stimulate EAT-16 directly to inhibit G q signaling in C. elegans neurons.
ACKNOWLEDGMENTS
We thank David Sierra for preparing Figures 1-3 ; Melanie Cobb, John Perkins, and members of our research groups for comments on the manuscript; and numerous colleagues for sharing preprints and unpublished information.
Visit the Annual Reviews home page at www.AnnualReviews.org LITERATURE CITED
